Systemic lupus erythematosus disproportionately affects racial and ethnic minorities in the United States, with devastating consequences for African American, Hispanic, and Asian Pacific Islander communities, according to new research from CDC-funded registries.
The comprehensive surveillance program examined over 5,400 lupus cases across multiple states and found stark disparities. African American women face the highest incidence rates, followed by Asian Pacific Islander and Hispanic women. Among American Indian and Alaska Native populations, the prevalence reached 270.6 per 100,000—the highest of any demographic studied.
Beyond diagnosis rates, minorities experience more severe disease manifestations. Nearly 50 percent of patients in some minority populations developed lupus nephritis, a serious kidney complication. Hispanic and Asian Pacific Islander patients also showed elevated risks for antiphospholipid syndrome.
The mortality gap proves equally troubling. Cardiovascular disease emerged as the leading cause of death across all groups, but Hispanic and Asian lupus patients died from heart-related causes at rates four to six times higher than the general population. Young Hispanic patients with lupus faced nearly 11 times the cardiovascular risk of their peers without the disease.
“When you see a young African American woman who has joint pains, or you do a urinalysis for a UTI and there’s like four plus protein in it, you should start thinking ‘maybe this patient has lupus,'” said Dr. Peter Izmirly, who co-directed the New York City registry.
The findings underscore urgent needs for earlier diagnosis and targeted interventions in vulnerable communities.
See: “Episode 1: Lupus by the Numbers: What the Data Reveals” (March 20, 2025)
